ClotTriever® Thrombectomy System Use-Result Survey in Japan
NCT ID: NCT06871683
Last Updated: 2026-02-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
100 participants
OBSERVATIONAL
2025-02-17
2028-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This device was designated as a subject of use results evaluation at the time of application for manufacturing and marketing approval.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
JETi Lower Extremity Venous Thrombosis
NCT07027878
Post-Market Evaluation of Active Thrombectomy and Proximal Aspiration During Lower Extremity Tibial Interventions
NCT06929832
JETi Lower Extremity Arterial Thrombosis
NCT04370691
Tourniquet Study: A Clinical Trial Into the Effect of Tourniquet Use on the Coagulation System
NCT02567903
Non-elastic Compression Garment Therapy Versus Control for Deep Vein Thrombosis
NCT03368313
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Full Analysis Population
All subjects who the survey device entered their vasculature.
ClotTriever® Thrombectomy System
ClotTriever® Thrombectomy System use for treatment of patients with deep vein thrombosis with acute severe symptoms.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ClotTriever® Thrombectomy System
ClotTriever® Thrombectomy System use for treatment of patients with deep vein thrombosis with acute severe symptoms.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vorpal Technologies
UNKNOWN
Inari Medical
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chiba University Hospital
Chuo, Chiba, Japan
Ota Memorial Hospital
Ōta, Gunma, Japan
St. Marianna University Hospital
Kawasaki, Kanagawa, Japan
National Cerebral and Cardiovascular Center
Suita, Osaka, Japan
Asahikawa Medical Hospital
Asahikawa, , Japan
Asahi General Hospital
Chiba, , Japan
Nozaki Tokushukai Hospital
Daitō, , Japan
Shonan Kamakura
Kanagawa, , Japan
Kyoto Katsura Hospital
Kyoto, , Japan
Nara City Hospital
Nara, , Japan
Mie University
Tsu, , Japan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
24-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.